The current paper reports on a study examining the use of a tabletbased multimedia intervention to increase HIV test rates among patients in a New York City hospital Emergency Department (ED) serving the Harlem area. The findings from this qualitative analysis of 40 ED patient interviews indicates how tablet-based multimedia can be expanded and adapted to serve a wide-range of at-risk populations and address salient public health concerns including the reduction of blood-borne disease transmission, drug overdose reduction, and increasing the health, empowerment and well-being of historically stigmatized and marginalized populations in global contexts.
INTRODUCTION
Harlem, NYC and other low socio-economic status (SES) neighborhoods face multiple public health challenges including exceptionally high HIV risk, [1] and problematically low HIV test rates. [2] Moreover, rates of HCV infection and opioid-related drug morbidity and mortality are growing problems. [3] [4] [5] 
METHODS
We present qualitative findings from 40 ED patients whose narrative accounts can help efforts to better understand how multimedia interventions can be adapted for different populations in a range of settings and be tailored to address pressing public health concerns including HIV and HCV, as well as overdose (OD) prevention, treatment, and response. All participants received treatment in a high volume Harlem area ED, and were interviewed after completing a brief (<15 minute) tablet-based multimedia intervention designed to increase HIV test rates. The intervention integrated automated data collection instruments (including an HIV risk screening) with short videos designed to address established barriers to testing. At the end of the intervention, the tablets asked each participant if they would like an HIV test.
We report on three salient domains including: 1) participant impressions of tablet-based multimedia video interventions; 2) participant suggestions for improvement of multimedia interventions and 3) participants' perspectives of additional venues and delivery modes for multimedia interventions. Participants' narrative accounts can assist in increasing efficacy of public health programmatic development and service delivery aimed at HIV/HCV/OD prevention, awareness and response among diverse, hard-to-reach populations that remain underserved by current efforts. Descriptions of our methodology and findings can potentially inform other interventions aimed at high-need populations around the world.
FINDINGS

Overall Impressions of Video Intervention
Patients' accounts suggest that there remains a lack of knowledge concerning HIV, testing and managing HIV disease. Patients spoke to the issue of time constraints, and of "outing" oneself to other community members while at the same time realizing testing and "treatment" can be done in a confidential setting sans fear of the stigmatization directed towards "others" that remains pervasive in the USA. There are stereotypes that remain: that only gay communities or drug-using communities are vulnerable to HIV. This ideological carry-over rooted in racist and sexist myths continues to impact many community members' willingness to discuss health and wellness with others in their community, especially involving sex or drugs. Mobile-based technologies may help alleviate some of these fears in confidential, lowPermission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. 
Suggestions for Improving Intervention
Patients suggested several ways that the multimedia intervention could be improved or tailored for different populations. Many indicated the need to target younger populations who may be unaware of the risks for HIV or mistakenly believe HIV is a disease that only affects males. Patients also suggested that messaging could be tailored to a broad cross-section of populations -indicating, as one participant suggested, 
"I mean, it shows that HIV don't discriminate. A lot of people think it's a Black, Spanish -no. It ain't no Black
"No. I mean, I don't think they should like make it seem like only gay guys that get HIV, I would do a boy and a girl because anybody can get it. And it was me I would probably focus on like younger kids … they don't understand that you need to be safe and but then again I wouldn't know but I have seen a lot of girls just sleep around and catch things and stuff…
White, Hispanic female, age 25.
Venues and Delivery Modes for Tablet-based Mobile Intervention
Patients were interviewed in the ED but had many innovative suggestions for broader dissemination via commercials, billboards and other forms of community outreach: 
CONCLUSIONS
Participants' narrative accounts of their experiences with mobilebased public health interventions provide many lessons. These participants suggest that technologies can be useful to increase the efficacy of public health programmatic development and service delivery aimed at HIV/HCV/OD prevention, awareness and response, and can be adapted for diverse populations in many settings.
Participants' narratives underscore the feasibility, acceptability, and effectiveness of tablet-based multimedia interventions and offer ways in which they can increase knowledge, awareness and testing for HIV and help reduce the impact of other critical public health problems. Moreover, they suggest these technologies hold potential to improve the public health of many disadvantaged communities in global contexts, especially highlighting the value of low-threshold service delivery targeting hard-to-reach populations. Finally, these patients speak to the ways in which mobile-based technologies can augment HIV education and testing and speak to the potential for reducing harms associated with blood-borne disease transmission and infection as well as reducing drug-related harms more generally.
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